Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR Therapeutics
Biotech
Takeda welcomes new oncology chief from CRISPR—Chutes & Ladders
Ex-CRISPR Tx CMO lands at Takeda. Lexeo adds Pfizer rare disease leader as development chief. Merck & Co. leader to join Cartography.
Max Bayer
,
Gabrielle Masson
Feb 9, 2024 9:30am
Former CRISPR Tx CMO finds new home at Takeda
Feb 2, 2024 3:30pm
JPM24, Day 3: Gene editors talk BD; Roivant has cash to spend
Jan 10, 2024 4:38pm
CRISPR Tx director: It’s ‘still early days’ on sealing new deals
Jan 10, 2024 10:57am
Vertex cuts ties to CRISPR’s type 1 diabetes stem cell therapy
Jan 8, 2024 9:16am
Scorpion taps new CEO, CMO—Chutes & Ladders
Jan 5, 2024 9:30am